TAVOLATO, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 2639
EU - Europa 604
AS - Asia 322
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
SA - Sud America 1
Totale 3571
Nazione #
US - Stati Uniti d'America 2639
IT - Italia 319
CN - Cina 293
FI - Finlandia 87
SE - Svezia 85
DE - Germania 60
FR - Francia 25
IN - India 15
VN - Vietnam 12
UA - Ucraina 10
GB - Regno Unito 5
ES - Italia 4
EU - Europa 4
IE - Irlanda 4
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
MK - Macedonia 1
MY - Malesia 1
NL - Olanda 1
SG - Singapore 1
Totale 3571
Città #
Chandler 401
Fairfield 340
Woodbridge 295
Ann Arbor 241
Houston 230
Wilmington 172
Ashburn 141
Seattle 110
Cambridge 102
Jacksonville 81
Princeton 68
Roxbury 61
Medford 60
Beijing 52
Nanjing 50
Des Moines 28
Guangzhou 28
Shenyang 27
San Diego 26
Helsinki 23
Jinan 21
Nanchang 21
Hebei 20
Milan 17
Boardman 16
Changsha 15
Norwalk 13
Dong Ket 12
Tianjin 12
Jiaxing 9
Bologna 6
Kharkiv 6
Ningbo 6
Parma 5
Redmond 5
Bolzano 4
Dublin 4
Haikou 4
Hangzhou 4
Padova 4
Taiyuan 4
Lanzhou 3
Modena 3
Napoli 3
Pisa 3
Rome 3
Zhengzhou 3
Ancona 2
Catania 2
Chaoyang 2
Cuneo 2
Doglio 2
Fuzhou 2
Hefei 2
Imola 2
Kunming 2
Lainate 2
London 2
Montebelluna 2
Piove Di Sacco 2
Reggio Emilia 2
Rio Saliceto 2
Torino 2
Torre Annunziata 2
Treviso 2
Turin 2
Yellow Springs 2
Aquila 1
Arese 1
Bari 1
Bassano Romano 1
Borås 1
Brescia 1
Bristol 1
Brussels 1
Budrio 1
Campobasso 1
Camposampiero 1
Capo Rizzuto 1
Capoterra 1
Caserta 1
Cassano Delle Murge 1
Castel Maggiore 1
Castelfranco Veneto 1
Chongqing 1
Cologno Al Serio 1
Cornaredo 1
Costa Valle Imagna 1
Dearborn 1
Den Haag 1
Desio 1
Duncan 1
Ferentino 1
Fiumicino 1
Florence 1
Fontaniva 1
Frankfurt am Main 1
Geislingen an der Steige 1
Genova 1
Gonzaga 1
Totale 2835
Nome #
Interleuchina 2 (IL-2) e recettore solubile dell’IL-2 (sIL-2R) nella Sclerosi Multipla. 287
La Sintesi Intratecale di IgG nella Sclerosi Multipla: confronto fra Isoelectricfocusing, IgG index (indice di Link) e Intra-BBB IgG Syn Rate (formula di Tourtellotte). 170
Immunological findings in the CSF of HIV-1-infected patients. 96
Free light chains in the CSF in multiple sclerosis. 87
Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. 87
Central nervous system involvement in HIV infection. 86
Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro. 83
Severe dysphagia in lower cranial nerve involvement as the initial symptom of Wegener's granulomatosis. 82
Intrathecal synthesis of anti-HIV oligoclonal IgG in HIV-seropositive patients having no signs of HIV-induced neurologic diseases. 80
Humoral immunity in multiple sclerosis cerebrospinal fluid: role of the blood-brain barrier integrity in the detection of intrathecally synthesized immunoglobulins. 79
Study of the IgG oligoclonal bands in cerebral spinal fluid in multiple sclerosis by electroimmunofixation. 79
Experimental allergic encephalomyelitis in the monkey: humoral immunity and blood-brain barrier function. 78
Intrathecal cytokine synthesis in inflammatory and demyelinating diseases of the central nervous system. 77
Time-course of interleukin-2 receptor expression in interferon beta-treated multiple sclerosis patients. 77
DHPLC analysis of the MECP2 gene in Italian Rett patients 74
Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies 73
The spectrum of antineuronal autoantibodies in a series of neurological patients. 72
M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis. Implications for neurological HIV-1-related disease. 72
Transferrin Receptors in the Central Nervous System. 72
Bickerstaff's brainstem encephalitis: case report and Tc99m brain SPECT findings. 71
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. 70
Macrophage-colony stimulating factor (M-CSF) in the cerebrospinal fluid. 67
Loss of reliability and sensitivity of agarose isoelectric focusing and quantitative formulæ in the detection of intrathecally synthesized IgG on the presence of blood-brain barrier damage. 65
Effect of high-dose steroid therapy on T-cell subpopulations. A longitudinal study in MS patients. 62
Protection from experimental autoimmune encephalomyelitis (EAE): non-depleting anti-CD4 mAb treatment induces peripheral T-cell tolerance to MBP in PL/J mice. 59
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) in the study of cerebrospinal fluid proteins. 57
Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP. 56
Blood-brain barrier damage restricts the reliability of quantitative formulae and isoelectric focusing in detecting intrathecally synthesized IgG. 56
Monoclonal and oligoclonal immunoglobulin M in the cerebrospinal fluid. 55
Effect of parenteral administration of GM1 on cytokines and anti-ganglioside antibody patterns. Preliminary report in normal human individuals. 55
Immunotheray-reversed compulsive, monoaminergic, circadian rhthm disorder in Morvan Syndrome 52
Demonstration of cerebrospinal fluid specific protein after 2-DE. 46
Cytokines in cerebrospinal fluid and serum of Multiple Sclerosis patients. 43
Limitation of peroxidase staining in the detection of CSF IgA separated by agarose isoelectric focusing. 43
On the role of interleukin-2 (IL-2) in multiple sclerosis (MS). IL-2-mediated endothelial cell activation. 42
Mechanisms of peripheral T-cell tolerance induction by non-depleting anti-CD4 mAb treatment. 41
Cerebrovascular and neurological disorders associated with antiphospholipid antibodies in CSF and serum. 40
Myelo-optico-neuropathy in copper deficiency occurring after partial gastrectomy - Do small bowel bacterial overgrowth syndrome and occult zinc ingestion tip the balance? 39
Increased levels of IL-2 and sIL-2R in MS serum. 37
Gallo P, Piccinno M, Pagni S, Tavolato B. 37
Clinica e Patologia del NeuroAIDS. 37
Neurofibrillary tangles, Pick’s and Lewys’s bodies:an immunocytochemical study. 37
The CSF Transferrin/Tau ratio. 36
A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum. 35
IgG BMG and neurological disorders: a study by chromatofocusing and agarose IEF. 35
Transferrin receptors in rat central nervous system. An immunocytochemical study. 34
Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid. 33
Detection of IgG oligovlonal bands in uncencentrated CSF by means of agarose isoelectricfocusing, double immunofixation, peroxidase staining and avidin-biotin amplification. 32
Il Sistema Transferrina-Tau del Liquido Cerebrospinale. 31
Le vasculiti del sistema nervoso centrale: aspetti clinico-diagnostici 30
Isoelectricfocusing combined with chromatofocusing and Elisa for investigation of anti-MBP antibodies. 30
Anion-exchange chromatography and isoelectricfocusing of serum immunoglobulins. 29
Sclerosi Multipla 29
Il “mirror IgG pattern” nella diagnostica delle malattie neurologiche. 29
Tumor necrosis factor alpha (TNF alpha) and neurological diseases. Failure in detecting TNF alpha in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours. 26
Sclerosi Multipla: aspetti immunopatogenetici e clinici. 24
Improved detection of free light chains in unconcentrated CSF by agarose IEF and avidin-biotin-peroxidase staining. 24
Immunoglobulin light chain patterns in the cerebrospinal fluid. A study with special reference to the occurrence of free light chains in cerebrospinal fluid with and without oligoclonal immunoglobulin G. 23
L’analisi del Liquido Cerebrospinale nella Diagnostica Neuroimmunologica. 23
Soluble mediators of the immune response in cerebrospinal fluid and serum of patients with multiple sclerosis. 22
Malattie del Sistema Nervoso Centrale da Autoanticorpi in corso di Patologie Sistemiche 20
Neuroimmunologia dell’Infezione da HIV. 19
Immunoglobulin free light chains in Multiple Sclerosis cerebrospinal fluid. 19
Nuove prospettive terapeutiche per la Sclerosi Multipla. 16
Totale 3577
Categoria #
all - tutte 5825
article - articoli 3676
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2094
Totale 11595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201874 0000 00 00 545015
2018/2019433 74523 75 448 969118107
2019/2020795 15222636 7342 6772 135876637
2020/2021255 20251116 1124 1226 37132634
2021/2022586 4853126 3665 862 39533192
2022/2023687 138641692 130105 1055 77000
Totale 3577